Name (Synonyms) | Correlation | |
---|---|---|
drug642 | Control message Wiki | 1.00 |
drug1651 | Not bravery message Wiki | 1.00 |
drug618 | Community interest message Wiki | 1.00 |
drug170 | Anger message Wiki | 1.00 |
drug149 | Alteplase 100 MG [Activase] Wiki | 1.00 |
drug838 | Embarrassment message Wiki | 1.00 |
drug823 | Economic freedom message Wiki | 1.00 |
drug1019 | Guilt message Wiki | 1.00 |
drug150 | Alteplase 50 MG [Activase] Wiki | 1.00 |
drug322 | Baseline message Wiki | 1.00 |
drug1798 | Personal freedom message Wiki | 1.00 |
drug822 | Economic benefit message Wiki | 1.00 |
drug2565 | Trust in science message Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D013577 | Syndrome NIH | 0.11 |
D055371 | Acute Lung Injury NIH | 0.10 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.10 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.09 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This study tests different messages about vaccinating against COVID-19 once the vaccine becomes available. Participants are randomized to 1 of 12 arms, with one control arm and one baseline arm. We will compare the reported willingness to get a COVID-19 vaccine at 3 and 6 months of it becoming available between the 10 intervention arms to the 2 control arms. Study participants are recruited online by Lucid, which matches census based sampling in online recruitment.
Description: This is a self reported measure, immediately after the intervention message, of the likelihood of getting a COVID-19 vaccination within 3 months and then 6 months of it becoming available. During analysis, responses among those assigned to different intervention messages will be compared to those in the control group.
Measure: Intention to get COVID-19 vaccine Time: Immediately after intervention, in the same survey in which the intervention message is providedDescription: This is a validated scale. This scale will be used to assess the impact of the messages on vaccine confidence. (Outcome assessed only for the half of the sample that answers these items post-treatment)
Measure: Vaccine confidence scale Time: Immediately after intervention, in the same survey in which the intervention message is providedDescription: This is a measure of a willingness to persuade others to take the COVID-19 vaccine.
Measure: Persuade others item Time: Immediately after intervention, in the same survey in which the intervention message is providedDescription: This is a measure of a comfort with an unvaccinated individual visiting an elderly friend after a vaccine becomes available
Measure: Fear of those who have not been vaccinated Time: Immediately after intervention, in the same survey in which the intervention message is providedDescription: This is a scale composed of 4 items measuring the trustworthiness, selfishness, likeableness, and competence of those who choose not to get vaccinated after a vaccine becomes available
Measure: Social judgment of those who do not vaccinate Time: Immediately after intervention, in the same survey in which the intervention message is provided